Maastricht Multimodal Molecular Imaging Institute (M4I) , University of Maastricht , Universiteitssingel 50 , 6229 ER Maastricht , The Netherlands.
Janssen Research & Development , Turnhoutseweg 30 , 2340 Beerse , Belgium.
Anal Chem. 2018 Oct 16;90(20):11835-11846. doi: 10.1021/acs.analchem.8b01378. Epub 2018 Oct 4.
The liver is the primary organ involved in handling of bile salts, a class of amphipathic molecules with signaling activities as well as desired and detrimental detergent actions. To allow in-depth investigation of functions of bile salts in healthy and diseased liver, the spatial distribution of bile salt species within the liver needs to be studied. Therefore, the aim of our study was to determine hepatic bile salt distribution and identify specific lipid markers that define the structural elements of the liver. Matrix-assisted laser desorption/ionization-mass spectrometry imaging (MALDI-MSI) was used to monitor the spatial distribution of bile salts and lipids in liver sections of rat, dog, and patients with unaffected and cholestatic parenchyma. MALDI-MSI in negative ion mode showed the local presence of a variety of bile salts, predominantly taurine-conjugates, as localized patches of varying sizes (representing the bile ducts) throughout the liver tissue. Specific molecular markers were identified for the connective tissue (phosphatidic acids, e.g., [PA (18:0_18:1)-H]), the liver parenchyma (phosphatidylinositols, e.g., [PI (18:0_20:4)-H]), and the bile ducts (hydroxylated-sulfatides, e.g., [ST-OH (18:1_24:0)-H]). One of these sulfatides (at m/ z 906.6339) was found to be uniquely localized in a thin lining on the inside of the bile duct, colocalized with cytokeratins, and encased luminal bile salts. A similar distribution of the aforementioned sulfatide was observed, albeit in constricted ductular structures, in the liver of a patient with a mild clinical phenotype of primary sclerosing cholangitis (PSC). In contrast, sulfatides were virtually absent in the liver of patients with PSC and a severe clinical phenotype, with (atypical) cholanoids (e.g., the bile alcohol 5-cyprinolsulfate) abundant in the extra-ductular space and glyco(cheno)deoxycholic acid-3-sulfate localized to fibrotic connective tissue. The latter two molecular species were able to discriminate between healthy liver tissue ( n = 3) and tissue from PSC patients with a severe clinical phenotype ( n = 3). In conclusion, the distinct structural elements of the mammalian liver are characterized by specific classes of lipids. We propose that (hydroxylated-)sulfatides are specific molecular markers of the bile duct.
肝脏是处理胆汁盐的主要器官,胆汁盐是一类具有信号活性以及所需和有害去污剂作用的两亲分子。为了深入研究胆汁盐在健康和患病肝脏中的功能,需要研究肝脏内胆汁盐种类的空间分布。因此,我们的研究目的是确定肝内胆汁盐的分布,并确定定义肝脏结构元素的特定脂质标记物。基质辅助激光解吸/电离-质谱成像 (MALDI-MSI) 用于监测大鼠、狗和未受影响和胆汁淤积实质的患者肝组织切片中胆汁盐和脂质的空间分布。负离子模式下的 MALDI-MSI 显示出各种胆汁盐的局部存在,主要为牛磺酸缀合物,大小不一的局灶性斑块(代表胆管)遍布整个肝组织。为结缔组织(例如,[PA(18:0_18:1)-H])、肝实质(例如,[PI(18:0_20:4)-H])和胆管(例如,[ST-OH(18:1_24:0)-H])鉴定了特定的分子标记物。其中一种硫酸酯(m/z906.6339)被发现独特地定位于胆管内的一层薄衬里,与细胞角蛋白共定位,并包裹着管腔内的胆汁盐。在患有原发性硬化性胆管炎 (PSC) 轻度临床表型的患者肝脏中观察到类似的硫酸酯分布,尽管在狭窄的胆管结构中,但在患有 PSC 和严重临床表型的患者肝脏中硫酸酯几乎不存在,在管腔外空间中丰富的非典型胆烷酸(例如,5-胆甾醇硫酸盐)和糖(甲)脱氧胆酸-3-硫酸盐定位于纤维性结缔组织。后两种分子种类能够区分健康的肝组织(n=3)和具有严重临床表型的 PSC 患者的组织(n=3)。总之,哺乳动物肝脏的不同结构元素由特定类别的脂质来表征。我们提出,(羟基)硫酸酯是胆管的特异性分子标记物。